Bioresorbable stents: quo vantis?
作者信息
Kounis Nicholas G, Koniari Ioanna, Davlouros Periklis, Soufras George, Tsigkas Grigorios, Hahalis George
机构信息
Department of Cardiology, University of Patras Medical School, Rion, Patras, Achaia, Greece.
Department of Cardiology, Royal Bromptom Hospital, London, UK.
出版信息
J Thorac Dis. 2017 Nov;9(11):E1032-E1034. doi: 10.21037/jtd.2017.10.62.
Abstract
摘要
相似文献
1
Bioresorbable stents: quo vantis?生物可吸收支架：何去何从？
J Thorac Dis. 2017 Nov;9(11):E1032-E1034. doi: 10.21037/jtd.2017.10.62.
2
Quo vantis: cancer nursing in Europe.
Eur J Oncol Nurs. 2003 Mar;7(1):1-2. doi: 10.1054/ejon.2003.0230.
3
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
4
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验
Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.
5
The Current Literature on Bioabsorbable Stents: a Review.生物可吸收支架的最新文献综述。
Curr Atheroscler Rep. 2019 Nov 25;21(12):54. doi: 10.1007/s11883-019-0816-4.
6
Bioresorbable Stents in PCI.经皮冠状动脉介入治疗中的生物可吸收支架
Curr Cardiol Rep. 2016 Aug;18(8):74. doi: 10.1007/s11886-016-0750-9.
7
From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.从药物洗脱支架到生物可吸收支架；再到经皮冠状动脉介入治疗的新视野。
Expert Rev Med Devices. 2016;13(3):271-86. doi: 10.1586/17434440.2016.1143356. Epub 2016 Feb 12.
8
Bioresorbable stents: Current and upcoming bioresorbable technologies.生物可吸收支架：当前及即将出现的生物可吸收技术。
Int J Cardiol. 2017 Feb 1;228:931-939. doi: 10.1016/j.ijcard.2016.11.258. Epub 2016 Nov 12.
9
A review of bioresorbable scaffolds: hype or hope?生物可吸收支架综述：炒作还是希望？
Singapore Med J. 2017 Sep;58(9):512-515. doi: 10.11622/smedj.2016178. Epub 2016 Nov 21.
10
Bifurcation stenting with bioresorbable scaffolds: Quo vadis?
Catheter Cardiovasc Interv. 2016 Nov 15;88(6):863-864. doi: 10.1002/ccd.26840.
引用本文的文献
1
The euphoria, the warnings and the downfall of the current bioresorbale stents: could the journey be restarted?当前生物可吸收支架的热潮、警示与衰落：这段历程能否重启？
Korean J Intern Med. 2018 Sep;33(5):879-882. doi: 10.3904/kjim.2018.060. Epub 2018 Aug 30.
本文引用的文献
1
Analysis of the degradation and the tissue response to bi-layered 3D-printed scaffolds combining PLA and biphasic PLA/bioglass components - Guidance of the inflammatory response as basis for osteochondral regeneration.聚乳酸（PLA）与双相PLA/生物玻璃成分组合的双层3D打印支架的降解及组织反应分析——以炎症反应引导为基础的骨软骨再生研究
Bioact Mater. 2017 Jun 23;2(4):208-223. doi: 10.1016/j.bioactmat.2017.06.001. eCollection 2017 Dec.
2
Bioresorbable scaffolds versus metallic stents in routine PCI: the plot thickens.常规经皮冠状动脉介入治疗中生物可吸收支架与金属支架的比较：情况愈发复杂。
J Thorac Dis. 2017 Aug;9(8):2296-2300. doi: 10.21037/jtd.2017.07.72.
3
[Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].[对铂盐和紫杉烷类的超敏反应：皮肤试验和耐受性诱导程序的价值]
Ann Dermatol Venereol. 2017 Nov;144(11):685-695. doi: 10.1016/j.annder.2017.05.016. Epub 2017 Jul 29.
4
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy.2 年随访：Absorb 生物可吸收支架治疗冠状动脉疾病：7 项随机临床试验的系统评价和荟萃分析及一项个体化患者数据分析亚研究。
Lancet. 2017 Aug 19;390(10096):760-772. doi: 10.1016/S0140-6736(17)31470-8. Epub 2017 Jul 18.
5
Thrombotic responses to coronary stents, bioresorbable scaffolds and the Kounis hypersensitivity-associated acute thrombotic syndrome.冠状动脉支架、生物可吸收支架及与库尼斯超敏反应相关的急性血栓形成综合征的血栓形成反应
J Thorac Dis. 2017 Apr;9(4):1155-1164. doi: 10.21037/jtd.2017.03.134.
6
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents.依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架比较
J Am Coll Cardiol. 2017 Jun 27;69(25):3055-3066. doi: 10.1016/j.jacc.2017.04.011. Epub 2017 Apr 12.
7
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.生物可吸收支架与金属支架在常规 PCI 中的应用比较。
N Engl J Med. 2017 Jun 15;376(24):2319-2328. doi: 10.1056/NEJMoa1614954. Epub 2017 Mar 29.
8
Acidosis induced by carbon dioxide insufflation decreases heparin potency: a risk factor for thrombus formation.二氧化碳注入引起的酸中毒会降低肝素效力：血栓形成的一个危险因素。
Perfusion. 2017 Apr;32(3):214-219. doi: 10.1177/0267659116677307. Epub 2016 Oct 27.
9
Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings.极晚期支架血栓：冠状动脉内影像学及组织病理学和光谱学研究结果。
J Am Coll Cardiol. 2015 Oct 27;66(17):1901-14. doi: 10.1016/j.jacc.2015.08.853.
10
Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up.非 HIV 患者聚左旋乳酸注射后迟发性免疫介导的不良反应：临床发现和长期随访。
Dermatology. 2009;219(4):303-8. doi: 10.1159/000243804. Epub 2009 Oct 1.
Zotero 插件